Helix

OverviewSuggest Edit

Helix is a company focused on personal genomics. It provides comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Additionally, Helix offers a suite of DNA-powered products.

TypePrivate
Founded2015
HQSan Mateo, USMap
Websitehelix.com
Employee Ratings4.3More
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Oct 2020)165(+7%)
Revenue (FY, 2018)$10 M(+67%)
Cybersecurity ratingBMore

Key People/Management at Helix

Marc Stapley

Marc Stapley

Chief Executive Officer
Marc Laurent

Marc Laurent

VP, Partnerships and Operations
Debbie Tuck

Debbie Tuck

Chief Financial Officer
James Lu

James Lu

Co-founder & Chief Scientific Officer
Justin Kao

Justin Kao

Co-founder & Chief Business Officer
Sarah Bobulsky

Sarah Bobulsky

VP, Strategy & Marketing
Show more

Helix Office Locations

Helix has offices in San Mateo and San Diego
San Mateo, US (HQ)
101 S Ellsworth Ave
San Diego, US
9875 Towne Centre Dr
Show all (2)

Helix Financials and Metrics

Summary Metrics

Founding Date

2015

Helix total Funding

$333 m

Helix latest funding size

$33 m

Time since last funding

3 months ago

Helix investors

Kleiner Perkins, DFJ Growth, Sutter Hill Ventures, Temasek Holdings, LaunchCapital, Warburg Pincus, National Institutes of Health, Illumina, Mayo Clinic, Mayo Clinic Ventures
Helix's latest funding round in July 2020 was reported to be $33 m. In total, Helix has raised $333 m
Show all financial metrics

Helix Revenue

Helix's revenue was reported to be $10 m in FY, 2018 which is a 66.7% increase from the previous period.
USD

Revenue (Q1, 2019)

1.0m

EBIT (Q1, 2019)

(18.0m)
Annual
USDFY, 2017FY, 2018

Revenue

6.0m10.0m

Revenue growth, %

67%

Depreciation and amortization

6.0m

EBIT

(90.0m)
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Revenue

1.0m2.0m1.0m3.0m3.0m2.0m1.0m

EBIT

(16.0m)(22.0m)(21.0m)(20.0m)(23.0m)(18.0m)

EBIT margin, %

(800%)(2200%)(700%)(667%)(1150%)(1800%)
show all
Annual
USDFY, 2017FY, 2018

Total Assets

45.0m154.0m
Quarterly
USDQ2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Total Assets

37.0m59.0m155.0m199.0m177.0m134.0m
show all
Show all financial metrics

Helix Operating Metrics

Mar, 2018Feb, 2020

DNA Tests

11

Products

35
Show all operating metrics

Helix Acquisitions / Subsidiaries

Company NameDateDeal Size
HumanCodeJune 28, 2018

Helix Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

Learn more about about our premium products
SecurityScorecard logo

Helix Online and Social Media Presence

Helix's Trends

Embed Graph

Helix Blogs

May 27, 2020

Beyond the cough: symptoms and trends from a COVID-19 survey

Our team of researchers are currently working through the data, but we have already found some interesting insights in our collection of survey responses, and we’ve contributed our findings to a worldwide research effort, consisting of renowned scientists from around the globe. These results, descri…
May 27, 2020

What did we learn from >10,000 COVID-19 survey responses?

Our team of researchers are currently working through the data, but we have already found some interesting insights in our collection of survey responses, and we’ve contributed our findings to a worldwide research effort, consisting of renowned scientists from around the globe. These results, descri…
May 15, 2020

Saliva-based COVID-19 testing is less sensitive than nasopharyngeal swabs in the community setting

Helix researchers, along with collaborators from Renown Health and UC San Diego, found that, relative to nasopharyngeal swabs, the sensitivity of saliva was approximately 30% lower in a community-based diagnostic cohort and 50% lower in a convalescent cohort The post Saliva-based COVID-19 testing i…
April 03, 2020

Revealing variants in SARS-CoV-2 interaction domain of ACE2 and loss of function intolerance through analysis of >200,000 exomes

Our analysis suggests that variants in the ACE2 gene--particularly those in the regions that interact with the SARs-COV-2 virus--have the potential to show important associations with COVID-19 susceptibility and resistance. The post Revealing variants in SARS-CoV-2 interaction domain of ACE2 and los…
January 22, 2020

The versatile and flexible Exome+™ assay?

Helix’s Exome+ assay has been carefully optimized to provide the benefits of targeted panels and the completeness of whole exome sequencing. The post The versatile and flexible Exome+™ assay? appeared first on Helix.
November 08, 2019

Learning about DNA with strawberries and Helix!

Many of us here at Helix became interested in science at an early age through hands-on demonstrations and fun (often messy) experiments, so we were excited to connect with all the students and young scientists to help them feel the same way at this year’s WorldWidewomen Girls’ Festival in San Franci…
Show more

 Helix Frequently Asked Questions

  • When was Helix founded?

    Helix was founded in 2015.

  • Who are Helix key executives?

    Helix's key executives are Marc Stapley, Marc Laurent and Debbie Tuck.

  • How many employees does Helix have?

    Helix has 165 employees.

  • What is Helix revenue?

    Latest Helix annual revenue is $10 m.

  • What is Helix revenue per employee?

    Latest Helix revenue per employee is $60.6 k.

  • Who are Helix competitors?

    Competitors of Helix include 23andMe, MyHeritage and Orig3n.

  • Where is Helix headquarters?

    Helix headquarters is located at 101 S Ellsworth Ave, San Mateo.

  • Where are Helix offices?

    Helix has offices in San Mateo and San Diego.

  • How many offices does Helix have?

    Helix has 2 offices.